Evaluation of Leptin and Adiponectin Levels in Patients with Stable Angina Pectoris

BACKGROUND Leptin and adiponectin are two adipose tissue hormones and their association with the incidence of cardiovascular diseases is under evaluation. The aim of this study was to determine the relationship of leptin and adiponectin with coronary artery diseases. METHODS One hundred and seventy patients with angina pectoris and indications of coronary angiography underwent angiography. Serum levels of blood lipids, leptin, and adiponectin were measured. The gathered data was evaluated using SPSS15 software, by multivariate variance analysis. RESULTS Analysis of the data demonstrated that 45.1% of the patients had positive angiographic findings. The serum levels of leptin and adiponectin were significantly lower than the minimum levels specified by the kit. However, the two groups, i.e., patients with positive angiographic findings and those with negative findings were not significantly different according to the serum levels of the hormones. Moreover, no significant correlation between the serum levels of the hormones and serum lipids was observed. CONCLUSION Various studies have demonstrated that high serum level of leptin and the incidence of coronary artery diseases are correlated. On the other hand, they have reported that adiponectin has cardioprotective role. Confirmation of these findings requires more detailed studies.

[1]  P. Papathanasopoulos,et al.  Acute post-stroke adiponectin in relation to stroke severity, progression and 6 month functional outcome , 2010, Neurological research.

[2]  C. Meisinger,et al.  Leptin, adiponectin, their ratio and risk of Coronary Heart Disease: results from the MONICA/KORA Augsburg Study 1984-2002. , 2010, Atherosclerosis.

[3]  Y. Yu,et al.  The Relationship between Plasma Level of Adiponectin and Coronary Lesion Complexity in the Population of North-East China , 2009, The Journal of international medical research.

[4]  C. Lavie,et al.  Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. , 2009, Journal of the American College of Cardiology.

[5]  Hong-jie Wang,et al.  Potential Role of Adipocytokine Leptin in Acute Coronary Syndrome , 2008, Asian cardiovascular & thoracic annals.

[6]  J. Bełtowski,et al.  Leptin and atherosclerosis. , 2006, Atherosclerosis.

[7]  Alan D. Lopez,et al.  Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data , 2006, The Lancet.

[8]  R. Ahima.  Central actions of adipocyte hormones , 2005, Trends in Endocrinology & Metabolism.

[9]  T. Kadowaki,et al.  Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.

[10]  Bruce D. Johnson,et al.  Plasma leptin and prognosis in patients with established coronary atherosclerosis. , 2004, Journal of the American College of Cardiology.

[11]  L. Weinehall,et al.  Leptin, but not adiponectin, predicts stroke in males , 2004, Journal of internal medicine.

[12]  W. Haynes,et al.  Leptin, obesity and cardiovascular disease , 2004, Current opinion in nephrology and hypertension.

[13]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[14]  N. Sarraf-zadegan,et al.  Isfahan Healthy Heart Programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience , 2003, Acta cardiologica.

[15]  A. Więcek,et al.  Decreased plasma concentration of a novel anti-inflammatory protein--adiponectin--in hypertensive men with coronary artery disease. , 2003, Thrombosis research.

[16]  T. Olsson,et al.  High Leptin Levels Are Associated with Stroke , 2003, Cerebrovascular Diseases.

[17]  S Margetic,et al.  Leptin: a review of its peripheral actions and interactions , 2002, International Journal of Obesity.

[18]  A. Mark,et al.  Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. , 2002, Journal of hypertension.

[19]  I. Shimon,et al.  Serum Leptin Levels Increase following Acute Myocardial Infarction , 2001, Cardiology.

[20]  T Nakamura,et al.  Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[21]  T Nakamura,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.

[22]  L. Weinehall,et al.  Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. , 1999, Stroke.

[23]  J. Barendregt,et al.  Global burden of disease , 1997, The Lancet.

[24]  P. Zimmet,et al.  Hyperleptinaemia: the Missing Link in the Metabolic Syndrome? , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[25]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[26]  D. Arveiler,et al.  Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study , 2010, International Journal of Obesity.

[27]  J. Chudek,et al.  Adipose tissue, inflammation and endothelial dysfunction. , 2006, Pharmacological reports : PR.

[28]  T. Funahashi,et al.  Decreased plasma adiponectin concentration in patients with essential hypertension. , 2003, American journal of hypertension.

[29]  Alan D. Lopez.  THE GLOBAL BURDEN OF DISEASE 1990-2020 , 2001 .

[30]  H. Chiba,et al.  Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. , 2000, Journal of atherosclerosis and thrombosis.

[31]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[32]  P. Libby,et al.  Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.